Nevertheless, a retrospective study has demonstrated that increased GPR43 expression in whole-blood samples of septic patients correlates with increased sepsis survival23, and GPR43 activation has been found to be beneficial for the treatment of lung infections46,47. The gene discussed is FFAR2; the disease is Sepsis.